New Bone Augmentation Material Patent Issued to BioLok.DEERFIELD BEACH, Fla. -- Bruce L. Hollander, BioLok's (OTCBB OTCBB See OTC Bulletin Board (OTCBB). :BLLI BLLI Broadband Low Layer Information ) President and Harold Alexander, PhD, President of BioLok's Orthogen Division, are extremely encouraged by research results from New York University New York University, mainly in New York City; coeducational; chartered 1831, opened 1832 as the Univ. of the City of New York, renamed 1896. It comprises 13 schools and colleges, maintaining 4 main centers (including the Medical Center) in the city, as well as the & UMDNJ UMDNJ University of Medicine and Dentistry of New Jersey - New Jersey Dental School New Jersey Dental School (abbreviated NJDS, also known as UMDNJ-NJDS) is one of eight schools that form the University of Medicine and Dentistry of New Jersey. Education New Jersey Dental School offers the following academic programs: DMD Program on the in-vitro and in-vivo testing of BoneGen TR, their newly patented time released calcium sulfate product. Both University research programs, headed by: Dennis Tarnow, DDS (1) (Digital Data Storage) See DAT. (2) (Data Dictionary System) See QuickBuild and OpenDDS. (3) (Dataphone Digital S at NYU and Saul Weiner, DDS at UMDNJ, are also evaluating the newly approved Silhouette Laser-Lok implants in side-by-side comparative studies with competitive products. Calcium Sulfate has been used safely for over 30 years as a bone augmentation material to fill small voids. It is a safe, non-biological source mineral product. It is fully absorbed naturally into the body without leaving behind trace contaminants. It forms a lattice to support the growth of natural bone and has been recently shown to encourage the growth of new blood vessels. The patent was issued for a "new" time - release version of calcium sulfate that allows doctors to fill all sizes of voids in bone, avoiding the too rapid absorption associated with filling large bony defects. By coating calcium sulfate with PLLA (polylactic acid, polymer), a material commonly used in absorbable sutures and bone tacks, we are able to slow absorption to better match the rate of new bone growth. Both calcium sulfate and PLLA are approved materials for use in the body so BioLok sees no major impediment to rapid regulatory approval for the combined ingredients as a single product. BioLok International Inc. is a publicly traded company publicly traded company A company whose shares of common stock are held by the public and are available for purchase by investors. The shares of publicly traded firms are bought and sold on the organized exchanges or in the over-the-counter market. that manufactures and distributes its dental implant system and bone regeneration products internationally. The worldwide dental implant market is in excess of $1.2 billion and growing at 13% per year. The worldwide bone augmentation market is approaching $1 billion and is also growing at 13% per year. Safe Harbor Statement under Private Securities Litigation Reform Act The Private Securities Litigation Reform Act of 1995 (PSLRA) implemented several significant substantive changes affecting certain cases brought under the federal securities laws, including changes related to pleading, discovery, liability, class representation and awards fees and of 1995: The statements contained in this release, which are not historical facts, may be deemed to contain, forward-looking statements, including, but not limited to, deployment of new services, growth of the customer base, and growth of the service area, among other items. Actual results may differ materially from those anticipated in any forward-looking statement with regard to magnitude, timing or other factors. Deviation may result from risk and uncertainties, including, without limitation, the company's dependence on third parties, market conditions for the sale of services, technical factors affecting networks, availability of capital and other risks and uncertainties. The company disclaims any obligation to update information contained in any forward-looking statement. |
|
Printer friendly
Cite/link
Email
Feedback
Reader Opinion